DEBIOPHARM INNOVATION FUND
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, transformative technologies that use AI and data to help patients. We do not invest in consumer wellness or workflow solutions. Our initial investment is typically $2-5M. Along with capital we bring deep pharma knowledge & networks and long-term commitment to help build value in your company. We are an evergreen investment fund of the pharmaceutical company Debiopharm based in Lausanne, Switzerland.
DEBIOPHARM INNOVATION FUND
Industry:
Venture Capital
Founded:
1979-01-01
Status:
Active
Contact:
418-650-3535
Technology used in webpage:
Apple Mobile Web Clips Icon Amazon ASP.NET IIS Amazon Virginia Region Java EE Lorem Ipsum WordPress 5.8 Apple Whitelist IIS 7
Similar Organizations
North East Technology Fund
North East Technology Fund is a venture capital firm invests in technology businesses.
Current Employees Featured
Tanja Dowe Chief Executive Officer @ Debiopharm Innovation Fund
Chief Executive Officer
2016-01-01
Thomas Gibbs Director @ Debiopharm Innovation Fund
Director
2012-01-01
Vincent Lepreux Associate Director @ Debiopharm Innovation Fund
Associate Director
2019-09-01
Cedric Odje Investment Analyst @ Debiopharm Innovation Fund
Investment Analyst
Nicole Wilson Senior Administrative Assistant @ Debiopharm Innovation Fund
Senior Administrative Assistant
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-09 | Mika | Debiopharm Innovation Fund investment in Series A - Mika | 10 M EUR |
| 2022-03-30 | VivoSense | Debiopharm Innovation Fund investment in Series A - VivoSense | 25 M USD |
| 2022-03-22 | Nucleai | Debiopharm Innovation Fund investment in Series B - Nucleai | 33 M USD |
| 2022-01-13 | VeriSIM Life | Debiopharm Innovation Fund investment in Series A - VeriSIM Life | 15 M USD |
| 2021-11-09 | Mekonos | Debiopharm Innovation Fund investment in Series A - Mekonos | 25 M USD |
| 2021-02-18 | Carevive Systems | Debiopharm Innovation Fund investment in Series C - Carevive Systems | 18 M USD |
| 2020-11-20 | Voluntis | Debiopharm Innovation Fund investment in Post-IPO Equity - Voluntis | N/A |
| 2020-09-09 | Oncomfort | Debiopharm Innovation Fund investment in Series A - Oncomfort | 10 M EUR |
| 2020-07-07 | Nucleai | Debiopharm Innovation Fund investment in Series A - Nucleai | 8.5 M USD |
| 2020-02-13 | Carevive Systems | Debiopharm Innovation Fund investment in Series C - Carevive Systems | 14.96 M USD |
More informations about "Debiopharm Innovation Fund"
Startup funding - Debiopharm
“At Debiopharm, we foresee a future where data sets the stage for the entire value chain of drug development, from generating novel drug designs to predicting clinical trial outcomes. The …See details»
Debiopharm Innovation Fund Launches New Seed Funding …
About Debiopharm Innovation Fund Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, provides funding and guidance for companies …See details»
Debiopharm Innovation Fund - Crunchbase
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, …See details»
Debiopharm Innovation Fund SA
Debiopharm's strategic fund provides funding and guidance for companies with data-driven digital solutions aiming to change the way drugs are developed and the way cancer patients are …See details»
Debiopharm Innovation Fund investment portfolio
Nov 1, 2021 Debiopharm Innovation Fund's latest investment was on 06-Mar-2025 in MedaSystems, a company within the Enterprise Systems (Healthcare) industry. Data Transparency. Meet our data hygiene team. Discover how our …See details»
Debiopharm Innovation Fund | EuroQuity
About your organization / profile Debiopharm Innovation Fund is the strategic fund of Debiopharm, an independent biopharmaceutical company based in Switzerland. The fund invests in early …See details»
Planting seeds of success: A new early-stage fund in …
Apr 16, 2025 Debiopharm Innovation Fund, the Swiss biopharma’s strategic investing arm managing a $150 million fund, is looking to get involved earlier in the investment process with the launch of a new seed ...See details»
Debiopharm Innovation Fund: the New Name and Investment …
Mar 7, 2017 Part of Debiopharm Group™, a Swiss-headquartered global biopharmaceutical group of five companies, Debiopharm Innovation Fund’s mission is to invest in companies …See details»
Debiopharm Innovation Fund: A €141+ million …
Sep 29, 2023 Debiopharm Innovation Fund is eager to support young Seed startups by providing not only capital but also the wealth of knowledge garnered from years of investing at the nexus of technology, pharma R&D …See details»
Debiopharm Innovation Fund S.A. - life-sciences-europe.com
Jan 1, 2008 Part of Debiopharm Group™ – a Swiss-headquartered global biopharmaceutical group including five companies active in the life science areas of drug development, GMP …See details»
Debiopharm Innovation Fund: a new seed fund dedicated to …
Apr 3, 2025 About Debiopharm Innovation Fund. Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, provides funding and …See details»
Debiopharm Innovation Funds invests to accelerate the ... - BioAlps
Mar 12, 2025 Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, provides strategic funding and guidance for …See details»
Debiopharm Innovation Fund - Investments, Portfolio & Company …
Debiopharm Innovation Fund has made 30 investments. Their most recent investment was on Mar 5, 2025, when MedaSystems raised a new funding round. Debiopharm Innovation Fund …See details»
Debiopharm Innovation Fund Launches New Seed Funding …
Sep 28, 2023 Kicks off fund with two strategic investments. Lausanne, Switzerland – September 28th, 2023 – Debiopharm Innovation Fund, the strategic investment arm of Swiss …See details»
Debiopharm Innovation Fund Launches New Seed Funding …
Sep 28, 2023 About Debiopharm Innovation Fund Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, provides funding and …See details»
Debiopharm Innovation Fund: The New Name And Investment
Mar 7, 2017 Part of Debiopharm Group™, a Swiss-headquartered global biopharmaceutical group of five companies, Debiopharm Innovation Fund's mission is to invest in companies …See details»
Venture Leaders Biotech partner Debiopharm Innovation Fund …
Feb 10, 2023 With USD 150 Million in assets, Debiopharm Innovation Fund is launching a seed funding initiative to support up to 15 early-stage startups annually. Building on its history of …See details»
Debiopharm Innovation Fund - EU-Startups
Debiopharm Innovation Fund. Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical …See details»
Debiopharm Innovation Fund: Leading European Digital Health …
Dec 12, 2024 Debiopharm Innovation Fund is thrilled to announce our recognition as one of the Top 10 European Digital Health Investors by Galen Growth in their 2024 HT50 Core Investors …See details»
The devil’s in the detail: an appraisal of the use of innovative ...
Mar 27, 2025 The IFFIm prides itself on making aid-financing history by initially securing up to 23-year legally binding commitments from donors [].IFFIm self-assessments claim that in the …See details»